http://sellingsickness.com/February 20-22, 2012 at the Hyatt Regency on Capitol Hill, Washington, DC
2006 Inaugural Congress on Disease Mongering
in Australia marked a watershed in networking among health care reformers
and drug industry critics.
2010 Selling Sickness conference in Amsterdam
expanded the network and updated the work.
About
Selling Sickness 2013 will bring
together academic scholars, healthcare reformers, consumer advocates and
progressive health journalists to examine the global tide of disease mongering.
Conference will include topics
pertaining to disease-mongering such as: misleading marketing; ethics in
professional education; journalistic standards; social media; over-treatment;
new models for drug development and testing; whistleblowers; new conflict of
interest areas; health screening policies; impact on public health and
pocketbook.
The conference is designed to
encourage audience participation and increase collaboration among the
conference attendees.
Kim Witczak
Kim Witczak became involved in
pharmaceutical drug safety issues after the death of her husband, Tim “Woody”
Witczak in 2003 as a result of an undisclosed drug side effect. She has taken
her personal experience and turned it into advocacy/public awareness campaign
on drug safety which included the SSRI/suicide risk (which resulted in black
box warnings being added to antidepressants), DTC advertising, undue Pharma
influence, COI, PDUFA, and FDA reform. Kim has testified before US Senate on PDUFA/FDA
reform as well as numerous FDA Advisory Committees. In 2008 she was appointed
to the FDA’s Psychopharmacologic Drugs Advisory Committee as a Patient
Representative. In 2004, Kim launched www.woodymatters.com
in memory of Woody’s life and death as a resource for others that live every
day with the consequences of a flawed drug safety system.
No comments:
Post a Comment